
Please try another search
Sunshine Lake Pharma Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology. It offers Kewei for the treatment of influenza; Dongweien for the treatment of hepatitis C; and generic drugs for the treatment of infections caused by sensitive bacteria, namely Clarithromycin, Levofloxacin, and Moxifloxacin Hydrochlorid, as well as active pharmaceutical ingredients. The company also engages in the wholesale, retail, import, and export of drugs. The company was formerly known as Sunshine Lake Pharma Ltd. The company was founded in 2003 and is based in Dongguan, China.
Name | Age | Since | Title |
---|---|---|---|
Shengchao Wang | 43 | 2017 | Chief of Quality Division & Employee Representative Supervisor |
Shuang Li | 44 | 2015 | Deputy GM & Executive Director |
Zhonghua Luo | 42 | 2017 | Supervisor |
Ling Xiang | 44 | 2020 | Independent Non Executive Director |
Xuechen Li | 47 | 2020 | Independent Non-Executive Director |
Hao Chen | 50 | 2023 | Executive Director |
Jianxin Tang | 60 | 2015 | Independent Non-Executive Director |
Juncai Jiang | 43 | 2015 | GM & Executive Director |
Jinlong Tang | 56 | 2019 | Chairman of the Board of Supervisors |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review